Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

this anxiety is often heightened when doctors observe elevated Prostate-Specific Antigen (PSA) levels. But the question is: do rising PSA levels after prostate cancer treatment necessarily mean ...

Assessing prostate-specific antigen levels for 3 months after radical prostatectomy may help minimize overtreatment, according to findings in JAMA Oncology.

Prostate specific membrane antigen (PSMA) expression is prevalent in prostate cancer, preserved during malignant transformation, and increases in response to anti-androgen therapies, making it a ...

Patients, who were assessed monthly to check their hematological parameters and prostate-specific antigen (PSA) levels, also underwent imaging investigations every 3–4 months. In total ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Screening for the condition is not currently recommended because using the current test - which looks for levels of prostate specific antigen (PSA) in the blood - can falsely find men who do not ...

The prostate has various functions. These include producing the fluid that nourishes and transports sperm, secreting prostate-specific antigen ... doctor may check PSA blood levels regularly ...